TherapeuticsMD, Inc. Financing Cash Flow
TherapeuticsMD, Inc. (TXMD) reported Financing Cash Flow of $3.15 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2025-03-27
- TherapeuticsMD, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-09-30 was $19.73M, a 38.01% decline year-over-year.
- TherapeuticsMD, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-06-30 was -$119.99M, a 28134.11% decline year-over-year.
- TherapeuticsMD, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-03-31 was -$5.00M, a 105.21% decline year-over-year.
- TherapeuticsMD, Inc. net cash provided by (used in) financing activities for the quarter ending 2021-12-31 was $1.35M, a 95.73% decline year-over-year.
- TherapeuticsMD, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $3.15M.
- TherapeuticsMD, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $129.55M, a 60.49% increase from fiscal 2020.
- TherapeuticsMD, Inc. net cash provided by (used in) financing activities for fiscal 2020 was $80.72M, a 57.25% decline from fiscal 2019.
- TherapeuticsMD, Inc. net cash provided by (used in) financing activities for fiscal 2019 was $188.83M, a 16.00% increase from fiscal 2018.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $3.15M 10-K · filed 2025-03-27 | |||||||
| 2022-09-30 | $19.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$100.26M derived: sum of 2 quarters · filed 2022-11-14 | -$105.26M 10-Q · filed 2022-11-14 | -$103.91M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2022-06-30 | -$119.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$124.99M 10-Q · filed 2022-08-15 | -$123.63M derived: sum of 3 quarters · filed 2023-05-15 | -$91.81M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2022-03-31 | -$5.00M 10-Q · filed 2023-05-15 | -$3.65M derived: sum of 2 quarters · filed 2023-05-15 | $28.18M derived: sum of 3 quarters · filed 2023-05-15 | $28.60M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $33.17M derived: sum of 2 quarters · filed 2022-11-14 | $33.60M derived: sum of 3 quarters · filed 2022-11-14 | $129.55M 10-K · filed 2022-03-23 | ||||
| 2021-09-30 | $31.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $32.25M derived: sum of 2 quarters · filed 2022-11-14 | $128.20M 10-Q · filed 2022-11-14 | $159.90M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $428.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $96.38M 10-Q · filed 2022-08-15 | $128.08M derived: sum of 3 quarters · filed 2022-08-15 | $128.19M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $95.95M 10-Q · filed 2022-05-16 | $127.65M derived: sum of 2 quarters · filed 2022-05-16 | $127.76M derived: sum of 3 quarters · filed 2022-05-16 | $127.85M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $31.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $31.81M derived: sum of 2 quarters · filed 2022-03-23 | $31.90M derived: sum of 3 quarters · filed 2022-03-23 | $80.72M 10-K · filed 2022-03-23 | $80.72M 10-K · filed 2021-03-04 | |||
| 2020-09-30 | $106.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $200.00K derived: sum of 2 quarters · filed 2021-11-12 | $49.02M 10-Q · filed 2021-11-12 | $49.02M 10-Q · filed 2020-11-09 | $126.05M derived: sum of 4 quarters · filed 2022-03-23 | |||
| 2020-06-30 | $94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $48.92M 10-Q · filed 2021-08-04 | $48.92M 10-Q · filed 2020-08-07 | $125.95M derived: sum of 3 quarters · filed 2022-03-23 | $125.96M derived: sum of 4 quarters · filed 2022-03-23 | |||
| 2020-03-31 | $48.82M 10-Q · filed 2021-05-06 | $48.82M 10-Q · filed 2020-05-06 | $125.85M derived: sum of 2 quarters · filed 2022-03-23 | $125.86M derived: sum of 3 quarters · filed 2022-03-23 | $237.55M derived: sum of 4 quarters · filed 2022-03-23 | |||
| 2019-12-31 | $77.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $77.04M derived: sum of 2 quarters · filed 2022-03-23 | $188.73M derived: sum of 3 quarters · filed 2022-03-23 | $188.83M 10-K · filed 2022-03-23 | $188.83M 10-K · filed 2020-02-24 | |||
| 2019-09-30 | $8.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $111.70M derived: sum of 2 quarters · filed 2020-11-09 | $111.80M 10-Q · filed 2020-11-09 | $112.23M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2019-06-30 | $111.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $111.79M 10-Q · filed 2020-08-07 | $112.22M derived: sum of 3 quarters · filed 2021-03-04 | $202.23M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2019-03-31 | $100.11K 10-Q · filed 2020-05-06 | $530.00K derived: sum of 2 quarters · filed 2021-03-04 | $90.55M derived: sum of 3 quarters · filed 2021-03-04 | $162.84M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2018-12-31 | $429.89K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $90.45M derived: sum of 2 quarters · filed 2021-03-04 | $162.74M derived: sum of 3 quarters · filed 2021-03-04 | $162.79M 10-K · filed 2021-03-04 | ||||
| 2018-09-30 | $90.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $162.31M derived: sum of 2 quarters · filed 2019-11-08 | $162.36M 10-Q · filed 2019-11-08 | $162.36M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $72.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $72.34M 10-Q · filed 2019-08-09 | $72.34M derived: sum of 3 quarters · filed 2020-02-24 | $140.91M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $44.06K 10-Q · filed 2019-05-08 | $44.06K derived: sum of 2 quarters · filed 2020-02-24 | $68.62M derived: sum of 3 quarters · filed 2020-02-24 | $69.98M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $68.57M derived: sum of 2 quarters · filed 2020-02-24 | $69.93M derived: sum of 3 quarters · filed 2020-02-24 | $72.58M 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | $68.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $69.93M derived: sum of 2 quarters · filed 2018-11-08 | $72.58M 10-Q · filed 2018-11-08 | $72.59M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30 | $4.01M 10-Q · filed 2018-07-30 | $4.02M derived: sum of 3 quarters · filed 2019-02-27 | $4.02M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $2.65M 10-Q · filed 2018-05-07 | $2.66M derived: sum of 2 quarters · filed 2019-02-27 | $2.66M derived: sum of 3 quarters · filed 2019-02-27 | $2.92M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $11.02K derived: sum of 2 quarters · filed 2019-02-27 | $265.61K derived: sum of 3 quarters · filed 2019-02-27 | $137.23M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $1.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $255.61K derived: sum of 2 quarters · filed 2017-11-07 | $137.22M 10-Q · filed 2017-11-07 | $137.86M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-06-30 | $254.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $137.21M 10-Q · filed 2017-08-03 | $137.86M derived: sum of 3 quarters · filed 2018-02-23 | $170.21M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-03-31 | $136.96M 10-Q · filed 2017-05-03 | $137.60M derived: sum of 2 quarters · filed 2018-02-23 | $169.96M derived: sum of 3 quarters · filed 2018-02-23 | $170.45M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2015-12-31 | $642.75K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $33.00M derived: sum of 2 quarters · filed 2018-02-23 | $33.49M derived: sum of 3 quarters · filed 2018-02-23 | $92.97M 10-K · filed 2018-02-23 | ||||
| 2015-09-30 | $32.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $32.85M derived: sum of 2 quarters · filed 2016-11-04 | $92.33M 10-Q · filed 2016-11-04 | $92.36M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $491.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $59.98M 10-Q · filed 2016-08-05 | $60.01M derived: sum of 3 quarters · filed 2017-02-28 | $102.90M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $59.48M 10-Q · filed 2016-05-05 | $59.51M derived: sum of 2 quarters · filed 2017-02-28 | $102.41M derived: sum of 3 quarters · filed 2017-02-28 | $102.74M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $30.20K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $42.92M derived: sum of 2 quarters · filed 2017-02-28 | $43.26M derived: sum of 3 quarters · filed 2017-02-28 | $43.30M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $42.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $43.23M derived: sum of 2 quarters · filed 2015-11-05 | $43.27M 10-Q · filed 2015-11-05 | $42.96M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $334.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $374.29K 10-Q · filed 2015-08-07 | $64.36K derived: sum of 3 quarters · filed 2016-02-26 | $30.54M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $40.05K 10-Q · filed 2015-05-07 | -$269.87K derived: sum of 2 quarters · filed 2016-02-26 | $30.20M derived: sum of 3 quarters · filed 2016-02-26 | $33.19M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | -$309.93K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $30.16M derived: sum of 2 quarters · filed 2016-02-26 | $33.15M derived: sum of 3 quarters · filed 2016-02-26 | $73.99M 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $30.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $33.46M derived: sum of 2 quarters · filed 2014-11-07 | $74.30M 10-Q · filed 2014-11-07 | $79.82M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | $2.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $43.83M 10-Q · filed 2014-08-07 | $49.35M derived: sum of 3 quarters · filed 2015-03-12 | $51.30M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | $40.84M 10-Q · filed 2014-05-07 | $46.36M derived: sum of 2 quarters · filed 2015-03-12 | $48.31M derived: sum of 3 quarters · filed 2015-03-12 | $52.71M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | $5.52M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $7.47M derived: sum of 2 quarters · filed 2015-03-12 | $11.87M derived: sum of 3 quarters · filed 2015-03-12 | $14.44M 10-K · filed 2015-03-12 | ||||
| 2012-09-30 | $1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $6.35M derived: sum of 2 quarters · filed 2013-11-05 | $8.92M 10-Q · filed 2013-11-05 | $10.77M derived: sum of 4 quarters · filed 2014-03-05 | ||||
| 2012-06-30 | $4.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $6.97M 10-Q · filed 2013-08-07 | $8.82M derived: sum of 3 quarters · filed 2014-03-05 | $10.17M derived: sum of 4 quarters · filed 2014-03-05 | ||||
| 2012-03-31 | $2.57M 10-Q · filed 2013-05-10 | $4.42M derived: sum of 2 quarters · filed 2014-03-05 | $5.77M derived: sum of 3 quarters · filed 2014-03-05 | $6.91M derived: sum of 4 quarters · filed 2014-03-05 | ||||
| 2011-12-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-05 | $3.20M derived: sum of 2 quarters · filed 2014-03-05 | $4.34M derived: sum of 3 quarters · filed 2014-03-05 | $4.71M 10-K · filed 2014-03-05 | ||||
| 2011-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $2.48M derived: sum of 2 quarters · filed 2012-11-13 | $2.85M 10-Q · filed 2012-11-13 | $155.00K 10-Q · filed 2011-11-07 | ||||
| 2011-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $1.50M 10-Q · filed 2012-08-09 | $99.00K 10-Q · filed 2011-08-15 | |||||
| 2011-03-31 | $367.24K 10-Q · filed 2012-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |